Phoenix Financial’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $306K | Buy |
583
+64
| +12% | +$33.6K | ﹤0.01% | 340 |
|
|
2025
Q1 | $329K | Sell |
519
-1,584
| -75% | -$1.01M | 0.01% | 288 |
|
|
2024
Q4 | $1.5M | Buy |
2,103
+336
| +19% | +$239K | 0.02% | 196 |
|
|
2024
Q3 | $1.86M | Buy |
1,767
+817
| +86% | +$860K | 0.03% | 190 |
|
|
2024
Q2 | $998K | Sell |
950
-383
| -29% | -$402K | 0.02% | 216 |
|
|
2024
Q1 | $1.28M | Buy |
1,333
+456
| +52% | +$438K | 0.02% | 214 |
|
|
2023
Q4 | $797K | Buy |
877
+239
| +37% | +$217K | 0.01% | 222 |
|
|
2023
Q3 | $535K | Sell |
638
-739
| -54% | -$620K | 0.01% | 230 |
|
|
2023
Q2 | $974K | Buy |
1,377
+714
| +108% | +$505K | 0.02% | 213 |
|
|
2023
Q1 | $533K | Buy |
+663
| New | +$533K | 0.01% | 214 |
|
|
2022
Q4 | – | Sell |
-447
| Closed | -$313K | – | 320 |
|
|
2022
Q3 | $313K | Sell |
447
-100
| -18% | -$70K | 0.01% | 267 |
|
|
2022
Q2 | $325K | Sell |
547
-1,429
| -72% | -$849K | 0.01% | 297 |
|
|
2022
Q1 | $1.38M | Sell |
1,976
-337
| -15% | -$235K | 0.02% | 226 |
|
|
2021
Q4 | $1.49M | Sell |
2,313
-232
| -9% | -$149K | 0.02% | 217 |
|
|
2021
Q3 | $1.54M | Buy |
+2,545
| New | +$1.54M | 0.03% | 232 |
|
|
2021
Q2 | – | Sell |
-2,494
| Closed | -$1.18M | – | 381 |
|
|
2021
Q1 | $1.18M | Buy |
2,494
+1,927
| +340% | +$908K | 0.03% | 272 |
|
|
2020
Q4 | $270K | Buy |
+567
| New | +$270K | 0.01% | 317 |
|